Handelsinvest Investeringsforvaltning Blueprint Medicines Corp Transaction History
Handelsinvest Investeringsforvaltning
- $208 Million
- Q1 2024
A detailed history of Handelsinvest Investeringsforvaltning transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Handelsinvest Investeringsforvaltning holds 3,876 shares of BPMC stock, worth $341,359. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,876
Previous 5,888
34.17%
Holding current value
$341,359
Previous $543,000
32.23%
% of portfolio
0.18%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$585 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$576 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$517 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$285 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$217 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.26B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...